AKT1 and carcinoma: LMP2A induces the phosphorylation of AKT, activates the PI3K/AKT pathway, and simultaneously inhibits epithelial cell differentiation in EBV-infected cells, and it is suggested that this process occurs via the same mechanism that contributes to the progression of carcinomas and lymphomas associated with EBV.